Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis.

IF 0.3 Q4 SURGERY
Thoracic and Cardiovascular Surgeon Reports Pub Date : 2021-01-01 Epub Date: 2021-01-19 DOI:10.1055/s-0040-1721483
Maximilian Vondran, Bernd Abt, Holger Nef, Ardawan J Rastan
{"title":"Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis.","authors":"Maximilian Vondran,&nbsp;Bernd Abt,&nbsp;Holger Nef,&nbsp;Ardawan J Rastan","doi":"10.1055/s-0040-1721483","DOIUrl":null,"url":null,"abstract":"<p><p>Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs). The new self-expanding transcatheter heart valve Allegra, from New Valve Technology with its special implantation mechanism, has proven its safety and feasibility for patients with degenerated SAVs, but it has never been used in the latest-generation sutureless SAV. To the best of our knowledge, this is the first description of the successful VIV of the Allegra prosthesis into a degenerated sutureless SAV, and the procedure yielded an excellent postinterventional hemodynamic results.</p>","PeriodicalId":41729,"journal":{"name":"Thoracic and Cardiovascular Surgeon Reports","volume":" ","pages":"e1-e5"},"PeriodicalIF":0.3000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0040-1721483","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic and Cardiovascular Surgeon Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0040-1721483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs). The new self-expanding transcatheter heart valve Allegra, from New Valve Technology with its special implantation mechanism, has proven its safety and feasibility for patients with degenerated SAVs, but it has never been used in the latest-generation sutureless SAV. To the best of our knowledge, this is the first description of the successful VIV of the Allegra prosthesis into a degenerated sutureless SAV, and the procedure yielded an excellent postinterventional hemodynamic results.

Abstract Image

Abstract Image

Abstract Image

阿利格拉经导管心脏瓣膜内退化无缝合主动脉生物假体。
经导管主动脉瓣内植入术(VIV)越来越多地被用于成功治疗退行性外科主动脉瓣生物假体(SAVs)。来自new valve Technology的新型自扩张经导管心脏瓣膜Allegra以其特殊的植入机制,已被证明其用于退行性SAV患者的安全性和可行性,但尚未在最新一代无缝线SAV中使用。据我们所知,这是首例将Allegra假体成功植入无缝线SAV的病例,该手术获得了良好的介入后血流动力学结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信